Inhibition of glycosphingolipid synthesis by threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol (PDMP) and the modulation of IL-1β-stimulated expression of inducible nitric oxide synthase in rat aortic smooth muscle cells

British Journal of Pharmacology

Volumn 123, Issue 5, 1998, Pages 906-910

  Weber, Artur Aron ^a,b   Seul, Claudia ^a   Harth, Volker ^a   Ko, Yon ^a   Seewald, Stefan ^a   Vetter, Hans ^a   Sachinidis, Agapios ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Glycosphingolipids; iNOS; Nitric oxide; Nitrite; Vascular smooth muscle cells

Indexed keywords

2 DECANOYLAMINO 3 MORPHOLINO 1 PHENYL 1 PROPANOL; CYTOKINE; GALACTOSE; GLYCOSPHINGOLIPID; INTERLEUKIN 1BETA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRITE; OXYHEMOGLOBIN;

ANIMAL CELL; AORTA ATHEROSCLEROSIS; AORTA MEDIA; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; RESTENOSIS; THIN LAYER CHROMATOGRAPHY; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELLS, CULTURED; ENZYME INDUCTION; GLYCOSPHINGOLIPIDS; INTERLEUKIN-1; MORPHOLINES; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS;

EID: 0031908282     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701674     Document Type: Article

References (29)

1. ANITSCHKOW, N. & CHATATOV, S. (1983). On experimental cholesterin steatosis and its significance in the origin of some pathological processes. Arteriosclerosis, 3, 178-182.
2. BARBOUR, S., EDIDIN, M., FELDING-HABERMANN, B., TAYLOR-NORTON, J., RADIN, N.S. & FENDERSON, B.A. (1992). Glycolipid depletion using a ceramide analogue PDMP alters growth, adhesion, and membrane lipid organization in human A431 cells. J. Cell. Physiol., 150, 610-619.
3. BEASLEY, D., SCHWARTZ, J.H. & BRENNER, M.J. (1991). Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. J. Clin. Invest., 87, 602-608.
4. BRECKENRIDGE, W.C., HALLORAN, J.L., KOVACS, K. & SILVER, M.D. (1975). Increase of gangliosides in atherosclerotic human aortas. Lipids, 10, 256-259.
5. BUSSE, R. & FLEMING, I. (1996). Endothelial dysfunction in atherosclerosis. J. Vasc. Res., 33, 181- 194.
6. BUSSE, R. & MÜLSCH, A. (1990). Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett., 275, 87-90.
7. CAYETTE, A.J., PALACINO, J.J., HORTON, K. & COHEN, R.A. (1994). Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler. Thromb., 14, 753-759.
8. COOKE, J.P., SINGER, A.H., TSAO, P., ZERA, P., ROWAN, R.A. & BILLINGHAM, M.E. (1992). Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J. Clin. Invest., 90, 1168-1172.
9. DURANTE, W., SCHINI, V.B., SCOTT-BURDEN, T., JUNQUERO, D.C., KROLL, M.H., VANHOUTTE, P.M. & SCHAFER. A.I. (1991). Platelet inihbition by an L-arginine-derived substance released by IL-1 β-treated vascular smooth muscle cells. Am. J. Physiol., 30, H2024-H2030.
10. FREIMAN, P.C., MITCHELL, G.G., HEISTAD. D.D., ARMSTRONG, M.L. & HARRISON, D.G. (1986). Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res., 58, 783-789.
11. LOSCALZO J. & WELCH, G. (1995). Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis., 38, 87-104.
12. MAZUROV, A.V , PROKAZOVA, N.V., MIKHAILENKO, I.A. MUKHIN, D.N., REPIN, V.S. & BERGELSON, L.D. (1988). Stimulation of platelet adhesion and activation by ganglioside GD3 adsorbed to plastic. Biochim. Biophys. Acta, 238, 167-171.
13. MILHAILENKO, I.A., DUBROVSKAYA, S.A., KOREPANOVA, O.B., TIMOFEEVA, N.G., MOROZKIN, A.D., PROKAZOVA, N.V. & BERGELSON, L.D. (1991) Interaction of low-density lipoproteins with gangliosides. Biochim. Biophys. Acta. 1085, 299-305.
14. MINOR, R.L., MYERS, P.R., GUERRA, R., BATES, J.N. & HARRISON, D.G. (1990). Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J. Clin. Invest., 86, 2109-2116.
15. MISKO, T.P., SSHILLING, R.J., SALVEMINI. D., MOORE, W.M. & CURRIE, M.G. (1993). A fluorometric assay for the measurement of nitrite in biological samples. Anal. Biochem., 241, 11-16.
16. MUKHIN, D.N., CHAO, F-F & KRUTH, H.S. (1995). Glycosphingolipid accumulation in the aortic wall is another feature of human atherosclerosis. Arterioscler. Thromb. Vasc. Biol., 15, 1607-1615.
17. POMERANTZ, K.B., HAJJAR, D.P., LEVI, R. & GROSS, S.S. (1993). Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. Biochem. Biophys. Res. Commun., 191, 103-109.
18. PROKAZOVA, N.V. & BERGELSON, L.D. (1994). Gangliosides and atherosclerosis. Lipids, 29, 1-5.
19. PROKAZOVA, N.V., MIKHAILENKO, I.A. & BERGELSON, L.D. (1991). Ganglioside GM3 stimulates the uptake and processing of low density lipoproteins by macrophages. Biochem. Biophys. Res. Commun., 177, 582-587.
20. RANI, C.S.S., ABE, A., CHANG, Y., ROSENZWEIG, N., SALTIEL, A.R., RADIN, N.S. & SHAYMAN, J.A. (1995). Cell cycle arrest induced by an inhibitor of glucosylceramide synthase. J. Biol. Chem., 270, 2859-2867.
21. ROSS, R (1990). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 362, 801-809.
22. 2 and vascular smooth muscle cell proliferation. Hypertension. 26, 771-780.
23. SCHINI, V.B., CATOVSKY, S., SCHRAY-UTZ, B., BUSSE, R. & VANHOUTTE, P.M. (1994). Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells. Circ. Res., 74, 24-32.
24. SCHINI, V.B., JUNQUERO, D.C., SCOTT-BURDEN, T. & VANHOUTTE, P.M. (1991). Interleukin-1 β induces the production of L-arginine-derived relaxing factor from cultured smooth muscle cells from rat aorta. Biochem. Biophys. Res. Commun., 176, 114-121.
25. SCHINI-KERTH, V.B., FIBLTHALER, B., ANDERSON, T.T., FENTON, J.W., VANHOUTTE, P.M. & BUSSE, R. (1995). Thrombin prevents the expression of inducible nitric oxide synthase in vascular smooth muscle cells by a proteolytically-activated thrombin receptor. Thromb. Haemost., 74, 980-986.
26. SCHNAAR, R.L. (1994). Isolation of glycosphingolipids. Methods Enzymol., 230, 348-370.
27. SCOTT-BURDEN, T., SCHINI, V.B., ELIZONDO, E., JUNQUERO, D.C. & VANHOUTTE, P.M. (1992). Platelet-derived growth factor suppresses and fibroblast factor enhances cytokine-induced production of nitric oxide by cultured smooth muscle cells: effects on cell proliferation. Circ. Res., 71, 1088-1100.
28. SHAYMAN, J.A., MAHDIYOUN, S., DESHMUKH, G., BARCELON, F., INOKUCHI, J. & RADIN, N.S. (1990). Glucosphingolipid dependence of hormone-stimulated inositol triphosphate formation. J. Biol. Chem., 265, 12135-12138.
29. WEBER, A.-A., STROBACH, H. & SCHRÖR, K. (1993). Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur. J. Pharmacol., 247, 29-37.